188 related articles for article (PubMed ID: 8791859)
21. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006.
Su X; Jiang F; Qimuge ; Dai X; Sun H; Ye S
Sex Transm Dis; 2007 Dec; 34(12):995-9. PubMed ID: 17595594
[TBL] [Abstract][Full Text] [Related]
22. [Gonococcus: the disturbing development of strains resistant to ciprofloxacin].
Nau JY
Rev Med Suisse; 2006 Jan; 2(49):250. PubMed ID: 16493970
[No Abstract] [Full Text] [Related]
23. From the Centers for Disease Control and Prevention. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
JAMA; 1994 Jun; 271(22):1733-4. PubMed ID: 8196105
[No Abstract] [Full Text] [Related]
24. Increasing incidence of gonorrhea in Israel associated with countrywide dissemination of a ciprofloxacin-resistant strain.
Yagupsky P; Schahar A; Peled N; Porat N; Trefler R; Dan M; Keness Y; Block C
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):368-72. PubMed ID: 12072921
[TBL] [Abstract][Full Text] [Related]
25. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.
Wang SA; Lee MV; O'Connor N; Iverson CJ; Ohye RG; Whiticar PM; Hale JA; Trees DL; Knapp JS; Effler PV; Weinstock HS
Clin Infect Dis; 2003 Sep; 37(6):849-52. PubMed ID: 12955650
[TBL] [Abstract][Full Text] [Related]
26. Ciprofloxacin resistance in Neisseria gonorrhoeae.
Moodley P; Sturm AW
Lancet; 2001 Apr; 357(9264):1295-6. PubMed ID: 11421219
[No Abstract] [Full Text] [Related]
27. Dramatic increase in a single genotype of TRNG ciprofloxacin-resistant Neisseria gonorrhoeae isolates in men who have sex with men.
Palmer HM; Young H
Int J STD AIDS; 2006 Apr; 17(4):254-6. PubMed ID: 16595048
[TBL] [Abstract][Full Text] [Related]
28. Emergence of quinolone-resistant Neisseria gonorrhoeae in Pakistan.
Jabeen K; Khan E; Hasan R
Int J STD AIDS; 2006 Jan; 17(1):30-3. PubMed ID: 16409676
[TBL] [Abstract][Full Text] [Related]
29. From the Centers for Disease Control and Prevention. Fluoroquinolone resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
JAMA; 2000 Oct; 284(15):1917-9. PubMed ID: 11183745
[No Abstract] [Full Text] [Related]
30. [Increased Neisseria gonorrhoeae quinolone resistance in Amsterdam].
Peerbooms PG; Spaargaren J; Fennema JS; Cairo I; Coutinho RA
Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1899-900. PubMed ID: 11605315
[TBL] [Abstract][Full Text] [Related]
31. Low prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in Nuuk, Greenland.
Pedersen ML; Clausen-Dichow P; Poulsen P; Nyborg H; Jensen JS
Sex Transm Dis; 2013 Aug; 40(8):639-40. PubMed ID: 23859910
[TBL] [Abstract][Full Text] [Related]
32. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ontario, 1992-1994.
Harnett N; Brown S; Riley G; Terro R; Krishnan C
Can Commun Dis Rep; 1995 Feb; 21(3):17-20; discussion 20-1. PubMed ID: 7881379
[No Abstract] [Full Text] [Related]
33. Treatment failure with the use of ciprofloxacin for gonorrhea correlates with the prevalence of fluoroquinolone-resistant Neisseria gonorrhoeae strains in Bangladesh.
Rahman M; Alam A; Nessa K; Nahar S; Dutta DK; Yasmin L; Monira S; Sultan Z; Khan SA; Albert MJ
Clin Infect Dis; 2001 Mar; 32(6):884-9. PubMed ID: 11247712
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of ciprofloxacin resistance amongst strains of Neisseria gonorrhoeae isolated from commercial sex workers in Bangladesh.
Bhuiyan BU; Miah RA; Rahman M; Rahman KM; Albert MJ
J Antimicrob Chemother; 1998 Nov; 42(5):675-6. PubMed ID: 9848459
[No Abstract] [Full Text] [Related]
35. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.
Bala M; Ray K; Gupta SM; Muralidhar S; Jain RK
J Antimicrob Chemother; 2007 Sep; 60(3):582-6. PubMed ID: 17604320
[TBL] [Abstract][Full Text] [Related]
36. Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 May; 47(20):405-8. PubMed ID: 9622458
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in 2004-2006 in Bangui, Central African Republic; Yaoundé, Cameroon; Antananarivo, Madagascar; and Ho Chi Minh Ville and Nha Trang, Vietnam.
Cao V; Ratsima E; Van Tri D; Bercion R; Fonkoua MC; Richard V; Talarmin A
Sex Transm Dis; 2008 Nov; 35(11):941-5. PubMed ID: 18724270
[TBL] [Abstract][Full Text] [Related]
39. High incidence of treatment failure of Neisseria gonorrhoeae isolates to ciprofloxacin in male gonococcal urethritis in Delhi.
Chowdhry S; Pandhi D; Vidhani S; Bhalla P; Reddy BS
Int J STD AIDS; 2002 Aug; 13(8):564-7. PubMed ID: 12194741
[TBL] [Abstract][Full Text] [Related]
40. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
Shultz TR; Tapsall JW; White PA
Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
